June 13, 2014 — Cardinal Health announced the 2 millionth shipment of the Mynx Vascular Closure Device (VCD). The Mynx ...
Vascular Closure Devices
This channel includes news and new technology innovations for vascular closure devices used to rapidly seal and achive hemostatsis at vascular access sites in interventional cardiology procedures.
April 8, 2014 — Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million ...
April 08, 2014
April 1, 2014 — AccessClosure Inc. commercially launched its Mynx Ace vascular closure device, a safe and secure ...
April 01, 2014
March 21, 2014 — AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of ...
March 21, 2014Feature | Dave Fornell
There is no shortage of debate among interventional cardiologists over whether vascular closure devices should be used ...
September 13, 2013
Feature | Patrick Antoun, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus ...
September 13, 2013
May 28, 2013 — The U.S. District Court for the District of New Jersey approved an agreement under which Vascular ...
May 28, 2013February 19, 2013 — CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of ...
February 19, 2013
February 7, 2013 — Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket ...
February 07, 2013December 10, 2012 — Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the ...
December 10, 2012
November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United States ...
November 06, 2012
Feature | Dave Fornell
Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ...
August 29, 2012
Feature | Christopher Wilson, D.O.; Kerri Wing, R.N., BSN; Peter Wassmer, M.D., FACC, and Robert Sanchez M.D., FACC
The implementation of dedicated access site surveillance and educational programs, in tandem with pre-existent ...
August 29, 2012
Feature | Dave Fornell
Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR) ...
August 15, 2012July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human ...
July 06, 2012